Department of Neurologic Surgery, Mayo Clinic, Jacksonville, FL, USA.
City University of New York School of Medicine, New York, NY, USA.
Childs Nerv Syst. 2023 Jun;39(6):1545-1554. doi: 10.1007/s00381-023-05903-6. Epub 2023 Mar 14.
Intracranial cavernous malformations (CMs) are rare vascular malformations of the central nervous system in children. Infantile patients, being a developmentally vulnerable age group, pose a special challenge for management of these lesions. We pooled data from infantile patients diagnosed at our institution and individual cases published in the literature to provide input towards therapeutic decision-making.
A systematic search of PubMed, MEDLINE, Embase, and Scopus was performed in accordance with PRISMA guidelines to identify all reported cases of intracranial CMs in the literature for infantile patients aged ≤ 2 years. In addition, cases from our institution diagnosed between 2010 and 2020 were also included. Individual cases were pooled and analyzed for clinical presentation, natural history, and outcomes from conservative and surgical management.
A total of 36 cases were included, of which 32 were identified from the literature. Median age at presentation was 14 months (range: 2 days to 24 months) months; 53% (n = 19) were females. Most cavernomas (64%, 23/36) were supratentorial, while 30% (n = 11) were located in brainstem and 5.5% (n = 2) in the cerebellum. With the exception of one patient, all cases were reported to be symptomatic; seizures (n = 15/31, 48.3%) and motor deficits (n = 13/31, 42%) were the most common symptom modalities. A total of 13 patients were managed conservatively upon initial presentation. No symptomatic hemorrhages were observed during 26 total person-years of follow-up. A total of 77% (28/36) underwent surgery; either upfront (23/28, 82%) at initial presentation or following conservative management. Among 12 patients who had preoperative seizures, 11/12 (91.6%) achieved seizure freedom post-resection. Among 7 patients who presented with hemiparesis preoperatively, 5 (71%) demonstrated some improvement, while 1 remained unchanged, and another patient with a brainstem cavernous malformation had worsening of motor function postoperatively. Postoperative recurrence was noted in 3 cases (3/27, 11%).
Annual risk of repeat hemorrhage may be low for infantile patients with intracranial cavernous malformations; however, better follow-up rates and higher number of cases are needed to make a definitive assertion. Surgical resection may be associated with high rates of epilepsy cure and provide improvement in neurological function in a select number of cases.
颅内海绵状血管畸形(CMs)是儿童中枢神经系统罕见的血管畸形。婴儿期患者是发育脆弱的年龄段,因此对这些病变的管理提出了特殊挑战。我们汇集了我院诊断的婴儿患者的数据和文献中报道的个别病例,为治疗决策提供依据。
按照 PRISMA 指南,对 PubMed、MEDLINE、Embase 和 Scopus 进行系统检索,以确定文献中所有 2 岁以下颅内 CMs 的病例报告。此外,还纳入了我院 2010 年至 2020 年期间诊断的病例。对来自文献和我院的病例进行汇总分析,内容包括临床表现、自然病史以及保守和手术治疗的结果。
共纳入 36 例病例,其中 32 例来自文献。发病时的中位年龄为 14 个月(范围:2 天至 24 个月);53%(n=19)为女性。大多数海绵状血管畸形(64%,23/36)位于幕上,30%(n=11)位于脑干,5.5%(n=2)位于小脑。除 1 例患者外,所有病例均有症状;最常见的症状模式为癫痫发作(n=15/31,48.3%)和运动障碍(n=13/31,42%)。共有 13 例患者在初次就诊时接受了保守治疗。在 26 人年的随访中,没有观察到症状性出血。共有 28 例(77%)接受了手术治疗;其中 23 例(82%)在初次就诊时或保守治疗后进行了手术。在 12 例术前有癫痫发作的患者中,11 例(91.6%)术后癫痫发作得到控制。在术前有偏瘫的 7 例患者中,5 例(71%)有一定程度的改善,1 例无变化,另 1 例脑干海绵状血管畸形患者术后运动功能恶化。3 例(3/27,11%)患者术后复发。
颅内海绵状血管畸形患儿每年再次出血的风险可能较低;然而,需要更好的随访率和更多的病例来得出明确的结论。手术切除可能与癫痫治愈率高有关,并能改善部分病例的神经功能。